陈情令免费观看全集完整版_梁医生不可以季亭亭梁衍_强壮公弄得我次次高潮小说_东北少妇不带套对白第一次

掃碼關注公眾號           掃碼咨詢技術支持           掃碼咨詢技術服務
  
客服熱線:400-901-9800  客服QQ:4009019800  技術答疑  技術支持  質量反饋  人才招聘  關于我們  聯系我們
国产精品美女WWW爽爽爽视频,重囗味另类老妇,狠狠色婷婷久久一区二区三区
首頁 > 產品中心 > 一抗 > 產品信息
Goat Anti-HBsAg  antibody (bs-1557G)  
~~~促銷代碼KT202411~~~
訂購熱線:400-901-9800
訂購郵箱:sales@pxfqg.com
訂購QQ:  400-901-9800
技術支持:techsupport@pxfqg.com
說明書: 50ul  100ul  200ul
50ul/1180.00元
100ul/1980.00元
200ul/2800.00元
大包裝/詢價

產品編號 bs-1557G
英文名稱 Goat Anti-HBsAg  antibody
中文名稱 山羊抗人乙肝表面抗原抗體(包被)
別    名 L glycoprotein; L-HBsAg; LHB; Large S protein; Large surface protein; Major surface antigen; S; HBSAG_HBVC5.  
Specific References  (16)     |     bs-1557G has been referenced in 16 publications.
[IF=14.079] Hayashi S et al. A novel association between core mutations in hepatitis B virus genotype F1b and hepatocellular carcinoma in Alaskan Native People. Hepatology.2018.  CLEIA&ICF ;  Human.  
[IF=6.286] Yuki Takamatsu. et al. A novel anti-HBV agent, E-CFCP, restores Hepatitis B virus (HBV)-induced senescence-associated cellular marker perturbation in human hepatocytes. VIRUS RES. 2023 May;329:199094  ICC ;  Human.  
[IF=5.701] Ito Daisuke. et al. Spermidine enhances the efficacy of adjuvant in HBV vaccination in mice. Hepatology Communications. 2023 Mar;7(4):e0104  IHC ;  Mouse.  
[IF=5.23] Sakurai, Fuminori, et al. "Human induced-pluripotent stem cell-derived hepatocyte-like cells as an in vitro model of human hepatitis B virus infection." Scientific Reports 7 (2017): 45698.  IF(ICC) ;  Human.  
[IF=5.23] Nakabori, T., et al. "Sodium taurocholate cotransporting polypeptide inhibition efficiently blocks hepatitis B virus spread in mice with a humanized liver."Scientific reports 6 (2015): 27782-27782.  IHC-F ;  Human.  
[IF=5.02] Lai, M. W., et al. "Hepatocarcinogenesis in transgenic mice carrying hepatitis B virus pre-S/S gene with the sW172* mutation." Oncogenesis 5.12 (2016): e273.  WB ;  Mouse.  
[IF=4.996] Ouchida Tsunenori. et al. The specific core fucose-binding lectin Pholiota squarrosa lectin (PhoSL) inhibits hepatitis B virus infection in vitro. SCI REP-UK. 2023 Apr;13(1):1-12  IP ;  Human.  
[IF=4.45] Watanabe, Tsunamasa, et al. "Post-Exposure Prophylactic Effect of HBV-active Antiretroviral Therapy Against Hepatitis B Virus Infection." Antimicrobial Agents and Chemotherapy (2014): AAC-04459.  IF ;  Human.  
[IF=4.368] Kong et al. The enhanced expression of death receptor 5 (DR5) mediated by HBV X protein through NF-kappaB pathway is associated with cell apoptosis induced by (TNF-α related apoptosis inducing ligand) TRAIL in hepatoma cells. (2015) Virol.J. 12:192  RT-PCR ;  Human,?Bee,?Hepatitis B virus.  
[IF=4.18] Ito, H., et al. "Induction of humoral and cellular immune response to hepatitis B virus (HBV) vaccine can be upregulated by CpG oligonucleotides complexed with Dectin‐1 ligand." Journal of Viral Hepatitis (2016).  IHC-P ;  Mouse.  
[IF=3.41] Yu, Hao-Tong, et al. "Comparison of the patterns of antibody recall responses to HIV-1 gp120 and hepatitis B surface antigen in immunized mice." Vaccine (2016).  WB ;  Mouse.  
[IF=3.34] Okumura, Nobuaki, et al. "Negative regulation of hepatitis B virus replication by forkhead box protein A in human hepatoma cells." FEBS Letters (2015).  WB ;  Human.  
[IF=2.999] Okumura et al. Negative regulation of hepatitis B virus replication by forkhead box protein A in human hepatoma cells. (2015) FEBS.Lett. 589:1112-8  WB ;  Human.  
[IF=2.54] Xiang, A., et al. "A simple and rapid capillary chemiluminescence immunoassay for quantitatively detecting human serum HBsAg." European journal of clinical microbiology & infectious diseases 32.12 (2013): 1557-1564.  ELISA ;  Human.  
[IF=2.03] Ma, Yan-Xiu, et al. "Successful establishment and evaluation of a new animal model for studying the hepatitis B virus YVDD mutant." Archives of virology (2012): 1-7.  IHC-P ;  Mouse.  
[IF=0] Gong et al. Construction and expression of a recombinant eukaryotic expression plasmid containing the preS1-preS2-S genes of hepatitis B virus and the granulocyte-macrophage colony stimulating factor gene: A study of its immunomodulatory effects. (2013) Biomed.Re. 1:251-256  WB ;  Human.  
研究領域 微生物學  細菌及病毒  
抗體來源 Goat
克隆類型 Polyclonal
交叉反應 Human,HBV (predicted: Bee,Hepatitis B virus)
產品應用 WB=1:500-2000,IHC-P=1:100-500,IHC-F=1:100-500,IF=1:100-500,ELISA=1:5000-10000
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
理論分子量 44kDa
細胞定位 細胞膜 
性    狀 Liquid
濃    度 1mg/ml
免 疫 原 Recombinant HBsAg protein 
亞    型 IgG
純化方法 affinity purified by Protein A
緩 沖 液 0.01M PBS (pH7.4) with 0.02% Proclin300.
保存條件 Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles.
注意事項 This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
PubMed PubMed
產品介紹 Hepatitis B Virus (HBV) infection induces a disease state characterised by liver damage, inflammation and viral persistence. Infection also increases the risk of hepatocellular carcinoma. HBV belongs to the Hepadnaviridae family of viruses. Its genome consists of partially double stranded circular DNA. The DNA is enclosed in a nucleocapsid, or core antigen (HBcAg), which is surrounded by a spherical envelope (surface antigen or HBsAg). The core antigen shares its sequences with the e antigen (HBeAg) but no cross reactivity between the two proteins has been observed. The HBV genome also encodes a DNA polymerase that also acts as a reverse transcriptase. Hepatitis B infection is normally diagnosed from serological tests that detect HBsAg but as the disease progresses this antigen may no longer be present in the blood and tests for HBcAg are used. If HBsAg can be detected in the blood for longer than six months, chronic hepatitis B is diagnosed. The antigenic determinant of the protein moiety of the HBsAg determines specific characteristics of different serotypes and provides the basis of immunodetection. HBsAg has antigenic heterogeneity, specifically, two pairs of sub specific determinants, d/y and w/r allow the following combinations: adw, ayw, adr, ayr.

Function:
The large envelope protein exists in two topological conformations, one which is termed 'external' or Le-HBsAg and the other 'internal' or Li-HBsAg. In its external conformation the protein attaches the virus to cell receptors and thereby initiating infection. This interaction determines the species specificity and liver tropism. This attachment induces virion internalization predominantly through caveolin-mediated endocytosis. The large envelope protein also assumes fusion between virion membrane and endosomal membrane (Probable). In its internal conformation the protein plays a role in virion morphogenesis and mediates the contact with the nucleocapsid like a matrix protein.
The middle envelope protein plays an important role in the budding of the virion. It is involved in the induction of budding in a nucleocapsid independent way. In this process the majority of envelope proteins bud to form subviral lipoprotein particles of 22 nm of diameter that do not contain a nucleocapsid.

Subunit:
Li-HBsAg interacts with capsid protein and with HDV Large delta antigen. Isoform M associates with host chaperone CANX through its pre-S2 N glycan. This association may be essential for M proper secretion.

Subcellular Location:
Virion membrane.

Post-translational modifications:
Isoform M is N-terminaly acetylated at a ratio of 90%, and N-glycosylated at the pre-S2 region.
Myristoylated.

Similarity:
Belongs to the orthohepadnavirus major surface antigen family.

SWISS:
P03140

Gene ID:
944569

Database links:

Entrez Gene: 2828293 Hepatitis B virus

Entrez Gene: 944569 Hepatitis B virus

SwissProt: P03138 Hepatitis B virus

SwissProt: P03140 Hepatitis B virus

SwissProt: P03141 Hepatitis B virus

SwissProt: Q81157 Hepatitis B virus

SwissProt: Q81158 Hepatitis B virus

SwissProt: Q81159 Hepatitis B virus

SwissProt: Q81160 Hepatitis B virus



產品圖片
Sample: Lane 1: Recombinant HBsAg protein(bs-41420P) Primary: Anti-HBsAg (bs-1557G) at 1/1000 dilution Secondary: IRDye800CW Donkey anti-Goat IgG at 1/20000 dilution Predicted band size: 44 kDa Observed band size: 20 kDa
Paraformaldehyde-fixed, paraffin embedded (Hepatitis B virus infected human hepatocellular carcinoma); Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15min; Blocking buffer (normal goat serum) at 37°C for 30min; Antibody incubation with (HBsAg) Polyclonal Antibody, Unconjugated (bs-1557G) at 1:200 overnight at 4°C, followed by A594 conjugated Rabbit Anti-Goat IgG H&L secondary antibody (bs-0294R-A594) incubation and staining.
Measured by its binding ability in a indirect ELISA. Immobilized recombinant HBsAg protein (Cat. bs-41420P) at 2 μg/mL (100 μL/well) can bind ?Goat Anti-Human HBsAg Antibody, the EC50 is 29.14 ng/mL.
版權所有 2004-2026 www.pxfqg.com 北京博奧森生物技術有限公司
通過國際質量管理體系ISO 9001:2015 GB/T 19001-2016    證書編號: 00124Q34771R2M/1100
通過國際醫療器械-質量管理體系ISO 13485:2016 GB/T 42061-2022    證書編號: CQC24QY10047R0M/1100
京ICP備05066980號-1         京公網安備110107000727號